[(18)F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer

PURPOSE: Pathological complete response to the neoadjuvant therapy (NAT) for triple negative breast cancer (TNBC) is predictive of prolonged patient survival. Methods for early evaluation of NAT efficiency are still needed, in order to rapidly adjust the therapeutic strategy in case of initial non-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Jouberton, Elodie, Schmitt, Sébastien, Chautard, Emmanuel, Maisonial-Besset, Aurélie, Roy, Marie, Radosevic-Robin, Nina, Chezal, Jean-Michel, Miot-Noirault, Elisabeth, Bouvet, Yann, Cachin, Florent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944726/
https://www.ncbi.nlm.nih.gov/pubmed/31907640
http://dx.doi.org/10.1186/s13550-019-0587-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944726/
https://www.ncbi.nlm.nih.gov/pubmed/31907640
http://dx.doi.org/10.1186/s13550-019-0587-5

Ejemplares similares